These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32445357)

  • 1. A Novel Cell-Free Fluorescent Assay for HDL Function: Low Apolipoprotein A1 Exchange Rate Associated with Increased Incident Cardiovascular Events.
    Lorkowski SW; Brubaker G; Li L; Li XS; Hazen SL; Smith JD
    J Appl Lab Med; 2020 May; 5(3):544-557. PubMed ID: 32445357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSL112 Infusion Rapidly Increases APOA1 Exchange Rate via Specific Serum Amyloid-Poor HDL Subpopulations When Administered to Patients Post-Myocardial Infarction.
    Didichenko SA; Velkoska E; Navdaev AV; Greene BH; Lorkowski SW; Duffy D; Mears SJ; Wright SD; Gibson CM; Smith JD; Kingwell BA
    Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):855-869. PubMed ID: 36994730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.
    Li XM; Tang WH; Mosior MK; Huang Y; Wu Y; Matter W; Gao V; Schmitt D; Didonato JA; Fisher EA; Smith JD; Hazen SL
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1696-705. PubMed ID: 23520163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
    Liting P; Guoping L; Zhenyue C
    Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention.
    Tian M; Li R; Shan Z; Wang DW; Jiang J; Cui G
    Lipids Health Dis; 2019 Nov; 18(1):202. PubMed ID: 31744496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
    Pan L; Lu G; Chen Z
    Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
    Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
    Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A1-Unique Peptide as a Diagnostic Biomarker for Acute Ischemic Stroke.
    Zhao X; Yu Y; Xu W; Dong L; Wang Y; Gao B; Li G; Zhang W
    Int J Mol Sci; 2016 Mar; 17(4):458. PubMed ID: 27043525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U-shaped relationship between apolipoprotein A1 levels and mortality risk in men and women.
    Faaborg-Andersen CC; Liu C; Subramaniyam V; Desai SR; Sun YV; Wilson PWF; Sperling LS; Quyyumi AA
    Eur J Prev Cardiol; 2023 Mar; 30(4):293-304. PubMed ID: 36351048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDL and apolipoprotein A1 concentrations as markers of cholesterol efflux in middle-aged women: interaction with smoking.
    Kralova Lesna I; Poledne R; Pagacova L; Stavek P; Pitha J
    Neuro Endocrinol Lett; 2012; 33 Suppl 2():38-42. PubMed ID: 23183508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoA1/HDL-C ratio as a predictor for coronary artery disease in patients with type 2 diabetes: a matched case-control study.
    Ghaemi F; Rabizadeh S; Yadegar A; Mohammadi F; Asadigandomani H; Bafrani MA; Reyhan SK; Esteghamati A; Nakhjavani M
    BMC Cardiovasc Disord; 2024 Jun; 24(1):317. PubMed ID: 38914982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.
    Borja MS; Ng KF; Irwin A; Hong J; Wu X; Isquith D; Zhao XQ; Prazen B; Gildengorin V; Oda MN; Vaisar T
    J Lipid Res; 2015 Oct; 56(10):2002-9. PubMed ID: 26254308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between HDL-cholesterol and apolipoprotein A1 and the severity of coronary artery disease.
    Garfagnini A; Devoto G; Rosselli P; Boggiano P; Venturini M
    Eur Heart J; 1995 Apr; 16(4):465-70. PubMed ID: 7671890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men.
    Florvall G; Basu S; Larsson A
    J Gerontol A Biol Sci Med Sci; 2006 Dec; 61(12):1262-6. PubMed ID: 17234819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
    Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
    Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes.
    Lorkowski SW; Brubaker G; Rotroff DM; Kashyap SR; Bhatt DL; Nissen SE; Schauer PR; Aminian A; Smith JD
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32260470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of Apolipoprotein A1 and Lecithin:Cholesterol Acyltransferase in type 2 diabetes mellitus: Correlations with haptoglobin phenotypes.
    Awadallah S; Madkour M; Hamidi RA; Alwafa EA; Hattab M; Zakkour B; Al-Matroushi A; Ahmed E; Al-Kitbi M
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S543-S546. PubMed ID: 28416369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.